Literature DB >> 7568011

Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection.

M Yoshimura1, A Nishikawa, Y Ihara, S Taniguchi, N Taniguchi.   

Abstract

The beta 1-6 structure of N-linked oligosaccharides, formed by beta-1,6-N-acetylglucosaminyltransferase (GnT-V), is associated with metastatic potential. We established a highly metastatic subclone, B16-hm, from low metastatic B16-F1 murine melanoma cells. The gene encoding beta-1,4-N-acetylglucosaminyltransferase (GnT-III) was introduced into the B16-hm cells, and three clones that stably expressed high GnT-III activity were obtained. In these transfectants, the affinity to leukoagglutinating phytohemagglutinin was reduced, whereas the binding to erythroagglutinating phytohemagglutinin was increased, indicating that the level of beta 1-6 structure was decreased due to competition for substrate between intrinsic GnT-V and ectopically expressed GnT-III. Lung metastasis after intravenous injection of the transfectants into syngeneic and nude mice was significantly suppressed, suggesting that the decrease in beta 1-6 structure suppressed metastasis via a mechanism independent of the murine system. These transfectants also displayed decreased invasiveness into Matrigel and inhibited cell attachment to collagen and laminin. Cell growth was not affected. Our results demonstrate a causative role for beta 1-6 branches in invasion and cell attachment in the extravasation stage of metastasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568011      PMCID: PMC41045          DOI: 10.1073/pnas.92.19.8754

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  A rapid in vitro assay for quantitating the invasive potential of tumor cells.

Authors:  A Albini; Y Iwamoto; H K Kleinman; G R Martin; S A Aaronson; J M Kozlowski; R N McEwan
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

2.  Glycosyltransferase assays using pyridylaminated acceptors: N-acetylglucosaminyltransferase III, IV, and V.

Authors:  N Taniguchi; A Nishikawa; S Fujii; J G Gu
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

3.  A method for the determination of N-acetylglucosaminyltransferase III activity in rat tissues involving HPLC.

Authors:  A Nishikawa; S Fujii; T Sugiyama; N Taniguchi
Journal:  Anal Biochem       Date:  1988-05-01       Impact factor: 3.365

4.  Analysis of the role of glycosylation of the human fibronectin receptor.

Authors:  S K Akiyama; S S Yamada; K M Yamada
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

5.  Structural heterogeneity of sugar chains in immunoglobulin G. Conformation of immunoglobulin G molecule and substrate specificities of glycosyltransferases.

Authors:  S Fujii; T Nishiura; A Nishikawa; R Miura; N Taniguchi
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

6.  Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts.

Authors:  J W Dennis; K Kosh; D M Bryce; M L Breitman
Journal:  Oncogene       Date:  1989-07       Impact factor: 9.867

Review 7.  Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides.

Authors:  H Schachter
Journal:  Biochem Cell Biol       Date:  1986-03       Impact factor: 3.626

8.  Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.

Authors:  F Qian; A S Bajkowski; D F Steiner; S J Chan; A Frankfater
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

9.  Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.

Authors:  J W Dennis; S Laferté; C Waghorne; M L Breitman; R S Kerbel
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

10.  Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc:N-acetyllactosaminide beta 1----3-N-acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid.

Authors:  D H van den Eijnden; A H Koenderman; W E Schiphorst
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

View more
  75 in total

1.  Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.

Authors:  Anas M Abdel Rahman; Michael Ryczko; Miyako Nakano; Judy Pawling; Tania Rodrigues; Anita Johswich; Naoyuki Taniguchi; James W Dennis
Journal:  Glycobiology       Date:  2014-10-01       Impact factor: 4.313

Review 2.  Glycosylation defining cancer malignancy: new wine in an old bottle.

Authors:  Senitiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

Review 3.  Regulation of integrin functions by N-glycans.

Authors:  Jianguo Gu; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 4.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

5.  BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.

Authors:  Xiaoyan Shen; Myoung-Soon Hong; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

Review 6.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

7.  Bisecting GlcNAc Is a General Suppressor of Terminal Modification of N-glycan.

Authors:  Miyako Nakano; Sushil K Mishra; Yuko Tokoro; Keiko Sato; Kazuki Nakajima; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yasuhiko Kizuka
Journal:  Mol Cell Proteomics       Date:  2019-08-02       Impact factor: 5.911

8.  Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

Authors:  Adriana Casas; Gabriela Di Venosa; Silvia Vanzulli; Christian Perotti; Leandro Mamome; Lorena Rodriguez; Marina Simian; Angeles Juarranz; Osvaldo Pontiggia; Tayyaba Hasan; Alcira Batlle
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

9.  N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.

Authors:  Yoshinobu Kariya; Rika Kato; Satsuki Itoh; Tomohiko Fukuda; Yukinao Shibukawa; Noriko Sanzen; Kiyotoshi Sekiguchi; Yoshinao Wada; Nana Kawasaki; Jianguo Gu
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

Review 10.  Neural functions of bisecting GlcNAc.

Authors:  Yasuhiko Kizuka; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2018-06-16       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.